Cancer Hospital In India
BONE MARROW TRANSPLANT

The blood and bone marrow transplantation center at BIACH & RI has highly qualified BMT team with very stringent infection control norms which are critical for BMT patients. The Bone Marrow Transplantation (BMT) Unit comprised of 13 isolated rooms (9 Pre procedure Room & 4 Post procedure Rooms all equipped with HEPA Filtration Systems Our specially-designed unit is equipped with a highly efficient air flow and filter system to ensure a safe environment of care. We specialize in performing autologous transplants (in which cells are harvested from the patient themselves) for patients.

Our services include:

  • Evaluating patients for eligibility
  • Harvesting specialized stem cells
  • Cell processing and cryopreservation (cold storage)
  • Preparing/conditioning patients for the procedure
  • Infusion of stem cells
  • Preventing and managing complications

Patients undergo a comprehensive evaluation to determine whether they are fit to receive a transplant. If they are deemed eligible, we prepare them fully for the procedure. Allogeneic transplants (in which cells are harvested from a donor) are taken into consideration one year after autologous transplantation has begun.

Our specially-designed unit is equipped with a highly efficient air flow and filter system to ensure a safe environment of care.

    · Autologous Transplant (Stem Cells collected from one's own body)

    · Hodgkin's & Non Hodgkin's Lymphoma: For relapsed / refractory cases, it is standard therapy and in most such cases, it is the only curative option.

    · Myeloma: Although not curative, it is standard treatment as a part of initial therapy, as it prolongs survival substantially.

    · Leukemia: Acute Myeloid Leukemia as part of consolidation therapy, to increase chance of cure in this disease.

    · Allogenic Transplant (Stem Cells collected from someone else's body)

    · Several other genetic disorders, especially with single gene defects

    · Aplastic Anemia

    · Chronic Myeloid Leukemia

    · High Risk AML & Relapsed AML

    · Relapsed ALL (Acute Lymphocytic Leukemia)

    · As an option in several advanced or refractory haematological malignancies eg. follicular lymphoma, CLL, myeloma etc